Menna Overview

Here’s a quick overview of GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED 👀 — a Stevenage based business that started in 2012.

GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED

  • Company statusactive
  • Company No08283222
  • Age12 years 9 months Incorporated 6 November 2012
  • Officers8

Address

Gsk Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom

GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED is an active company incorporated on 6 November 2012 and based in Stevenage, United Kingdom. The company was registered 13 years ago.


  • Credit score0
  • Score change
    0

Unlock Business Credit Reports & Real-time Tracking with Menna

Quickly detect credit risks and protect your business.

signup-iconSign Up
  • Credit limit£
  • CCJs
    0

  • Company Type

    Private limited with Share Capital

  • Jurisdiction

    england & wales

  • Nature of business (SIC)

    64209 Activities of other holding companies n.e.c.

  • Accounts

    Available to 31 December 2024. Next accounts due by 30 September 2025

See filing history on Companies House

Latest Activity

face
Change Corporate Secretary Company With Change Date

1 Month Ago on 31 Jul 2025

face
Change Corporate Director Company With Change Date

1 Month Ago on 31 Jul 2025

face
Appoint Person Director Company With Name Date

1 Month Ago on 15 Jul 2025

face
Termination Director Company With Name Termination Date

1 Month Ago on 09 Jul 2025

event
Confirmation Statement With No Updates

10 Months Ago on 11 Oct 2024

face
Appoint Person Director Company With Name Date

11 Months Ago on 27 Sep 2024

face
Change Person Director Company With Change Date

11 Months Ago on 20 Sep 2024

face
Change Person Director Company With Change Date

11 Months Ago on 17 Sep 2024

face
Change Person Director Company With Change Date

11 Months Ago on 17 Sep 2024

face
Change Person Director Company With Change Date

11 Months Ago on 17 Sep 2024

face
Change Person Director Company With Change Date

11 Months Ago on 17 Sep 2024

finance
Accounts With Accounts Type Full

1 Year Ago on 22 Aug 2024

face
Termination Director Company With Name Termination Date

1 Year Ago on 31 Jul 2024

event
Change Sail Address Company With Old Address New Address

1 Year Ago on 18 Jul 2024

face
Appoint Person Director Company With Name Date

1 Year Ago on 11 Jul 2024

face
Termination Director Company With Name Termination Date

1 Year Ago on 05 Jul 2024

face
Appoint Person Director Company With Name Date

1 Year Ago on 15 Apr 2024

face
Appoint Person Director Company With Name Date

1 Year Ago on 02 Feb 2024

event
Confirmation Statement With No Updates

1 Year Ago on 05 Oct 2023

face
Termination Director Company With Name Termination Date

1 Year Ago on 20 Sep 2023

event
Change To A Person With Significant Control

2 Years Ago on 16 Aug 2023

face
Change Corporate Director Company With Change Date

2 Years Ago on 16 Aug 2023

finance
Accounts With Accounts Type Full

2 Years Ago on 16 Aug 2023

face
Appoint Person Director Company With Name Date

2 Years Ago on 02 Aug 2023

face
Termination Director Company With Name Termination Date

2 Years Ago on 20 Jul 2023

People

Officers8

Significant control (PSC)1

Officers

NameRoleDate of BirthAppointed
EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITEDcorporate secretary 06 Nov 2012
BARCELO IGLESIAS, Cristinadirector Oct 197723 Sept 2024
FENT, Anna Mary Harcourtdirector Nov 197810 Jul 2025
GURUNLU RUSS, Demetdirector Oct 197125 Jun 2024
RIVERS, Graham Pauldirector May 197118 Jul 2023
WALKER, Adamdirector Nov 196728 Mar 2013
EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITEDcorporate director 06 Nov 2012
GLAXO GROUP LIMITEDcorporate director 06 Nov 2012

PSC (Persons with Significant control)

NameDate of BirthAppointed
Glaxosmithkline Intellectual Property Management Limited 06 Apr 2016

Some of the data shown on this platform is sourced from third parties or public records. While we do our best to keep everything accurate and up to date, we do not control or guarantee the reliability, completeness, or accuracy of external data sources.